Internal Medicine, Cardiovascular Disease · San Jose, CA
NPI
1184650772
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
2516 Samaritan Dr, Suite A
San Jose, CA, 95124
Phone (408) 356-4242
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
10,659 services
Medicare patients, 2024
1,894
Average age 77
Drug cost, 2024
$3.3M
15,579 prescriptions
Company payments, 2025
$3,044
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Durga V Madala was code 99214 (office e&m - established), 3,220 times for 1,520 patients. In total Durga V Madala billed 10,659 services in 47 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 3,220 | 1,520 | $113.71 | $366K |
| 93000 Electrocardiogram | Office | 1,766 | 1,170 | $13.33 | $24K |
| 93306 Echocardiography (TTE/TEE) | Office | 1,297 | 1,178 | $198.29 | $257K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 654 | 649 | $196.89 | $129K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 540 | 136 | $5.51 | $2,978 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 520 | 156 | $0.52 | $271 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 309 | 156 | $11.11 | $3,432 |
| 99441 Telephone Services | Office | 269 | 240 | $53.46 | $14K |
| 93351 Echocardiography (TTE/TEE) | Office | 261 | 258 | $227.35 | $59K |
| 99233 Hospital E&M - Subsequent | Facility | 217 | 65 | $105.53 | $23K |
| 99204 Office E&M - New | Office | 199 | 199 | $151.80 | $30K |
| 93010 Electrocardiogram | Facility | 188 | 173 | $6.70 | $1,260 |
| 93015 Electrocardiogram | Office | 167 | 166 | $62.85 | $10K |
| 78452 Myocardial Perfusion Scan | Office | 156 | 156 | $460.37 | $72K |
| 93280 External Electrocardiographic Monitoring | Office | 144 | 104 | $76.16 | $11K |
By year: 2022 $763K for 9,541 services; 2023 $778K for 9,053 services; 2024 $1.1M for 10,659 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 121 | 14 | $4.24 | $513 |
Medicare prescription drug claims, 2024
In 2024, the drug Durga V Madala prescribed most often to Medicare patients was Amlodipine Besylate, with 1,645 prescriptions and refills. In total Durga V Madala wrote 15,579 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,645 | 4,506 | 496 | $14K |
| Atorvastatin Calcium Generic | 1,225 | 3,565 | 368 | $13K |
| Rosuvastatin Calcium Generic | 1,125 | 3,070 | 344 | $15K |
| Metoprolol Succinate Generic | 937 | 2,518 | 314 | $13K |
| Eliquis Apixaban | 803 | 1,633 | 209 | $936K |
| Ezetimibe Generic | 732 | 1,972 | 224 | $22K |
| Repatha Sureclick Evolocumab | 669 | 1,221 | 129 | $692K |
| Nebivolol Hcl Generic | 660 | 1,797 | 213 | $52K |
| Valsartan Generic | 531 | 1,456 | 157 | $16K |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 465 | 1,288 | 129 | $14K |
| Losartan Potassium Generic | 397 | 1,157 | 131 | $3,780 |
| Jardiance Empagliflozin | 358 | 633 | 101 | $361K |
| Furosemide Generic | 338 | 798 | 111 | $2,289 |
| Pravastatin Sodium Generic | 315 | 911 | 101 | $4,428 |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 291 | 828 | 93 | $11K |
Brand drugs: - claims; generic drugs: 12,555 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Durga V Madala $3,044 ($3,044 in general payments such as food, travel and fees) from 27 companies. The largest payer was Novo Nordisk Inc with $290.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 15 | $290 |
| Pfizer Inc. PFE | 14 | $272 |
| Esperion Therapeutics, Inc. ESPR | 13 | $239 |
| Novartis Pharmaceuticals Corporation NVS | 20 | $231 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $159 |
| Abbvie Inc. ABBV | 8 | $155 |
| Merck Sharp & Dohme LLC MRK | 6 | $147 |
| Philips North America LLC PHG | 6 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.